UBL Bio Corporation
PrivateLast Round
Seed
Dec 1, 2020
Total Funding Raised
$150,000
Company Overview
UBL Bio Corporation is a biotechnology company that develops anti-aging therapeutics by combining senescent-cell control technologies with artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UBL Bio Corporation Comparables
Compare UBL Bio Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lifeceutix | 83% | |
| Gero | 81% | |
| HaplScience | 79% |
UBL Bio Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2020 |
UBL Bio Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bluepoint Partners | Seed |
| Tech Incubator Program for Startups | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2020
$150K round led by Bluepoint Partners
UBL Bio Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about UBL Bio Corporation's valuation, stock price, and market status.
Is UBL Bio Corporation a public or private company?
UBL Bio Corporation is a private company.
What is the current stock price of UBL Bio Corporation?
UBL Bio Corporation is a private company with no public stock price. Caplight tracks UBL Bio Corporation's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is UBL Bio Corporation worth (valuation)?
Valuation information for UBL Bio Corporation is not publicly available.
Can I buy UBL Bio Corporation stock?
UBL Bio Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was UBL Bio Corporation's last funding round?
UBL Bio Corporation's most recent funding round was Seed on December 1, 2020.
Who are the main investors in UBL Bio Corporation?
Key investors in UBL Bio Corporation include Bluepoint Partners.
Will UBL Bio Corporation IPO soon?
No public IPO plans have been announced for UBL Bio Corporation.
How can I track UBL Bio Corporation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor UBL Bio Corporation's secondary market activity and sign up for updates.